Overview
Our stem cell research platform provides integrated solutions spanning induced pluripotent stem cell (iPSC) generation, characterization, differentiation, gene editing, expansion, and functional analysis. Supported by advanced electrophysiology and high-content imaging platforms, we help researchers develop physiologically relevant cell and organoid models for disease modeling, drug discovery, toxicity assessment, regenerative medicine, and cell therapy research.
Creative Bioarray's Stem Cell Research Services
iPSC Generation
Generation of induced pluripotent stem cells from a variety of somatic cell sources using validated reprogramming technologies. Services can be tailored to support disease modeling, gene editing projects, and cell therapy research.
iPSC Characterization
Comprehensive evaluation of pluripotency, self-renewal capacity, and cellular quality to confirm successful iPSC establishment.
iPSC Differentiation
Directed differentiation of iPSCs into specialized cell types and organoid systems for disease research, functional studies, and drug development.
Available Differentiation Services
Undifferentiated iPSC Detection
Sensitive detection of residual undifferentiated iPSCs in differentiated cell populations to support product quality assessment and safety evaluation.
iPSC Gene Editing
Genome engineering services for creating targeted genetic modifications in iPSCs using precise editing strategies to support disease modeling and functional genomics research.
iPSC Expanding Service
Expansion of iPSC cultures under controlled conditions while maintaining pluripotency, genomic stability, and cellular quality.
MSC Services
Mesenchymal stem cell-related services including isolation, expansion, characterization, and application support for regenerative medicine and translational research programs.
Stem Cell Assay Development and Screening
Customized assay development using stem cell-derived cellular models for mechanistic studies, target validation, efficacy testing, and toxicity evaluation.
Advanced Stem Cell Research Platforms
Maestro Multi-Well Microelectrode Array (MEA) Platform
The Maestro MEA Platform enables real-time, label-free assessment of electrophysiological activity in neuronal and cardiac cell models, including organoids. It supports functional studies of cellular networks for disease modeling, safety evaluation, and drug screening.
Advantages of the Platform:
- Non-invasive, label-free electrophysiological recording
- Real-time monitoring of neuronal and cardiac network activity
- Long-term studies under controlled environmental conditions
- Assessment of beating behavior, synchrony, rhythmicity, and network function
- Functional evaluation for disease modeling and compound screening
CellInsight™ CX5 High-Content Screening Platform
The CellInsight™ CX5 Platform combines automated imaging with quantitative cellular analysis to support both live-cell and fixed-cell studies. It enables multiparametric evaluation of cellular phenotypes, providing high-quality data for drug discovery, toxicity assessment, and mechanistic research.
Advantages of the Platform:
- Examination of intracellular fluorescence intensity changes.
- Analysis of marker protein distribution among cells and organelles.
- Visualization of protein colocalization within cells.
- Evaluation of cell morphology and size.
- Measurement of cell migration.
Research Applications
Disease Modeling
Patient-derived and engineered stem cell models for investigating disease mechanisms and therapeutic targets.
Drug Discovery
Stem cell-derived cellular systems for compound evaluation, efficacy testing, and phenotypic screening.
Functional Phenotyping
Electrophysiological and imaging-based characterization of cellular behavior and biological responses.
Regenerative Medicine
Research support for cell therapy development, tissue regeneration studies, and translational applications.
Why Choose Us
Comprehensive Stem Cell Expertise
Integrated capabilities spanning reprogramming, characterization, differentiation, and functional analysis.
Broad Cell and Organoid Portfolio
Multiple stem cell-derived models covering neural, cardiac, immune, metabolic, and organoid systems.
Advanced Analytical Platforms
Industry-recognized electrophysiology and high-content imaging technologies for quantitative data generation.
Flexible Project Support
Customized workflows designed to accommodate diverse research objectives and development programs.
